Natalie C. Holles

Director; Director, Chief Executive Officer and President · 3 filings · Latest: May 19, 2026

Aura Biosciences, Inc.

Day One Biopharmaceuticals, Inc.

LeonaBio, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
AURA	Natalie C. Holles	Director, Chief Executive Officer and President	May 19, 2026	Grant/Award	$0.00	1,153,962	—	1,153,962	May 19 4:59 PM
DAWN	Natalie C. Holles	Director	Apr 23, 2026	Disposition	—	57,310	—	0	Apr 23 4:37 PM